Unichem Laboratories Ltd. News and Updates

Keep track of all breaking news on Unichem Laboratories Ltd. from all sources in a single place.

Load latest

Unichem Laboratories Ltd.

03 Dec 2021

613.30

3.81%

Unichem Labs surges 15% on ANDA nod from USFDA for Aripiprazole tablets

Business Standard

Aripiprazole tablets are indicated for Schizophrenia and Irritability associated with Autistic Disorder

Unichem Laboratories Ltd.'s price crossed above 30Day SMA today

Unichem Laboratories share gains 7% on USFDA nod to Aripiprazole tablets

Moneycontrol | 03 Dec 2021

Unichem Laboratories Ltd.

26 Nov 2021

613.30

3.81%

Unichem Laboratories climbs 19% after ICRA reaffirms long-term rating

Moneycontrol

The share touched its 52-week high of Rs 374.90 and 52-week low of Rs 197.50 on May 21, 2021 and November 22, 2021, respectively.

Unichem Laboratories Ltd. is trading above its 30 day SMA of 593.8

Unichem Laboratories Ltd.

20 May 2021

613.30

3.81%

Unichem Labs gets USFDA nod to market generic antidepressant tablets

Business Standard

Drug firm Unichem Laboratories on Thursday said it has received approval from the US health regulator to market generic Amitriptyline HCl tablets used in the treatment of depression. The company has received abbreviated new drug application (ANDA) approval to market its Amitriptyline HCl tablets USP, in the strengths of 10 mg, 25 mg, 50 mg, 75 mg, 100 mg and 150 mg from the United States Food and Drug Administration (USFDA), Unichem Laboratories said in a regulatory filing. The product is a generic version of AstraZeneca Pharmaceuticals LP's Elavil tablets in the same strengths, it added. The tablets will be commercialised from the company's Goa plant, Unichem Labs said. Amitriptyline HCl Tablets are indicated for the relief of symptoms of depression, it added. Shares of Unichem Laboratories closed at Rs 358.60 per scrip on BSE, up 7.43 per cent from its previous close.

Unichem Laboratories Ltd. is trading below its 50 day SMA of 613.3

Unichem Laboratories Ltd.

19 Feb 2021

613.30

3.81%

Unichem Labs gets USFDA nod for plaque psoriasis drug

Business Line

Apremilast tablets are used to treat adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy

Unichem Laboratories Ltd. is trading below its 50 day SMA of 613.3

Unichem Labs zooms 6% on USFDA approval for Apremilast tablets

Business Line | 19 Feb 2021 2 more

Unichem Laboratories Ltd.

02 Feb 2021

613.30

3.81%

Unichem Labs Consolidated December 2020 Net Sales at Rs 326.28 crore, up 9.84% Y-o-Y

Moneycontrol

NULL

Unichem Laboratories Ltd. has lost -21.82% in the last 6 Months

Unichem Laboratories Ltd.

27 Jan 2021

613.30

3.81%

Unichem Laboratories gets USFDA nod to market generic capsules

Moneycontrol

The company has received abbreviated new drug application (ANDA) approval to market its Zonisamide capsules, USP 25 mg, 50 mg and 100 mg from the United States Food and Drug Administration (USFDA), Unichem Laboratories said in a BSE filing.

Unichem Laboratories Ltd. is trading above its 30 day SMA of 593.8

Unichem Laboratories Ltd.

13 Jan 2021

613.30

3.81%

Unichem Labs gets USFDA nod to market capsules to treat osteoarthritis

Business Standard

Drug firmUnichem Laboratories on Wednesday said it has received approval from the US health regulator to market its generic Celecoxib capsules

Unichem Laboratories Ltd. is trading above its 30 day SMA of 593.8

Unichem Laboratories gets USFDA nod to market generic Celecoxib capsules

Moneycontrol | 13 Jan 2021

Unichem Laboratories Ltd.

01 Dec 2020

613.30

3.81%

Unichem Laboratories shares rise 4% on USFDA approval for blood pressure tablets

Moneycontrol

The share touched its 52-week high Rs 304.20 and 52-week low Rs 75.10 on 04 August, 2020 and 24 March, 2020, respectively.

Unichem Laboratories Ltd. has lost -21.82% in the last 6 Months

Unichem Laboratories Ltd.

22 Jul 2020

613.30

3.81%

Unichem Laboratories gets USFDA nod for drug to treat irregular heartbeat

Moneycontrol

The company has received abbreviated new drug application (ANDA) approval for its Amiodarone tablets, USP, 200 mg from the United States Food and Drug Administration (USFDA), Unichem Labs said in a filing to the BSE.